CUSIP

Putnam Investments Announces 19(a) Notices for Closed-End Funds

Retrieved on: 
Wednesday, March 6, 2024

Putnam estimates that $0.0168 per share of Putnam Master Intermediate Income Trust’s dividend is paid from accumulated net investment income, and $0.0052 per share represents a return of capital.

Key Points: 
  • Putnam estimates that $0.0168 per share of Putnam Master Intermediate Income Trust’s dividend is paid from accumulated net investment income, and $0.0052 per share represents a return of capital.
  • These estimates and the sources of the fund's dividends and distributions are determined in accordance with accounting principles applicable to the fund.
  • A non-taxable return of capital, if any, cannot be determined until after the end of the fund's fiscal year.
  • Putnam estimates that $0.0193 per share of Putnam Premier Income Trust’s dividend is paid from accumulated net investment income, and $0.0067 per share represents a return of capital.

MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing

Retrieved on: 
Tuesday, March 5, 2024

MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, autoimmune and inflammatory conditions, today announced that it received notice from The Nasdaq Stock Market LLC ("Nasdaq") on March 4, 2024 informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (“Listing Rule”) for continued listing on the Nasdaq Capital Market.

Key Points: 
  • MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, autoimmune and inflammatory conditions, today announced that it received notice from The Nasdaq Stock Market LLC ("Nasdaq") on March 4, 2024 informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (“Listing Rule”) for continued listing on the Nasdaq Capital Market.
  • On October 11, 2023, MyMD received notice from the Listing Qualifications Department of Nasdaq indicating that the Company was not in compliance with the Listing Rule, as its common shares had failed to meet a closing bid price of $1.00 or more for 30 consecutive business days.
  • The Company conducted a 1-for-30 reverse split of its common stock on February 14, 2024, with the goal of increasing the trading price of the common stock.
  • For the Company to regain compliance with the Listing Rule, the Company’s common stock was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive business days.

New Fortress Energy Inc. Announces Increase to Previously Announced Cash Tender Offer for its 6.750% Senior Secured Notes due 2025

Retrieved on: 
Tuesday, March 5, 2024

For each $1,000 principal amount of Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date.

Key Points: 
  • For each $1,000 principal amount of Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date.
  • If the Tender Offer is not fully subscribed as of the Early Tender Date, Holders who validly tender Notes after the Early Tender Date may be subject to proration, whereas Holders who validly tender Notes at or prior to the Early Tender Date will not be subject to proration.
  • The Total Consideration includes an early tender payment (the “Early Tender Payment”) of $30.00 for each $1,000 principal amount of the Notes, which Early Tender Payment is in addition to the Tender Offer Consideration.
  • Holders must decide whether to tender Notes, and if tendering, the amount of Notes to tender.

New Fortress Energy Inc. Announces Cash Tender Offer for up to $250,000,000 of its 6.750% Senior Secured Notes due 2025

Retrieved on: 
Tuesday, March 5, 2024

(5) For each $1,000 principal amount of Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date.

Key Points: 
  • (5) For each $1,000 principal amount of Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date.
  • If the Tender Offer is not fully subscribed as of the Early Tender Date, Holders who validly tender Notes after the Early Tender Date may be subject to proration, whereas Holders who validly tender Notes at or prior to the Early Tender Date will not be subject to proration.
  • The Total Consideration includes an early tender payment (the “Early Tender Payment”) of $30 for each $1,000 principal amount of the Notes, which Early Tender Payment is in addition to the Tender Offer Consideration.
  • Holders must decide whether to tender Notes, and if tendering, the amount of Notes to tender.

Pagaya Announces Effective Date for Reverse Stock Split

Retrieved on: 
Monday, March 4, 2024

The reverse stock split was approved by the Company’s shareholders at a special meeting held on February 15, 2024.

Key Points: 
  • The reverse stock split was approved by the Company’s shareholders at a special meeting held on February 15, 2024.
  • Fractional shares will not be issued in connection with the reverse stock split.
  • The reverse stock split will affect all shareholders uniformly and will not alter any shareholder's relative interest in the company's equity, except for any adjustments for fractional shares.
  • The reverse stock split will reduce the number of the Company’s issued and outstanding Class A Ordinary Shares from approximately 605.1 million shares to approximately 50.4 million shares.

FGIC Announces Entry into Transaction Support Agreement to Pursue a Potential Accelerated Run-Off Transaction

Retrieved on: 
Thursday, February 29, 2024

A copy of this Transaction Support Agreement will be posted to FGIC’s website at www.fgic.com/proposedacceleratedrunoff/ .

Key Points: 
  • A copy of this Transaction Support Agreement will be posted to FGIC’s website at www.fgic.com/proposedacceleratedrunoff/ .
  • The total amount of Permitted Policy Distributions net of amounts allocable to FGIC-Owned Instruments is estimated to be about $1.480 billion.
  • A copy of this Novation Agreement will be posted to FGIC’s website at www.fgic.com/proposedacceleratedrunoff/ .
  • The Proposed Transaction will become effective only if, among other things, the required court approvals are obtained.

Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price

Retrieved on: 
Tuesday, February 27, 2024

The new CUSIP number for the Common Stock following the reverse split will be 928251206.

Key Points: 
  • The new CUSIP number for the Common Stock following the reverse split will be 928251206.
  • We believe this reverse split will allow us to regain compliance with Nasdaq’s minimum bid price requirement and to make our bid price more attractive to a broader universe of investors.
  • Stockholders whose shares are held in brokerage accounts should direct any questions concerning the reverse stock split to their broker.
  • The Nasdaq Capital Market requires, among other things, that a listed company’s common stock maintain a minimum bid price of at least $1.00 per share.

Edgio Announces Effectiveness of Reverse Stock Split

Retrieved on: 
Tuesday, February 27, 2024

As a result of the Reverse Stock Split, every forty (40) shares of the Company’s issued and outstanding common stock will be converted into one (1) share of issued and outstanding common stock.

Key Points: 
  • As a result of the Reverse Stock Split, every forty (40) shares of the Company’s issued and outstanding common stock will be converted into one (1) share of issued and outstanding common stock.
  • The Reverse Stock Split will be effected simultaneously for all of our outstanding Common Stock and the exchange ratio will be the same for all of our outstanding Common Stock.
  • The Reverse Stock Split will have no impact on stockholders’ proportionate equity interest or voting rights in the Company or the par value of the Common Stock, which remains unchanged, except to the extent that the Reverse Stock Split results in any of our stockholders receiving fair value in cash of any fractional shares they would otherwise be entitled to as a result of the Reverse Stock Split.
  • Following the Reverse Stock Split, stockholders will receive instructions from Edgio’s transfer agent on how a stockholder should surrender his or her certificate(s) representing shares of Common Stock to the transfer agent in exchange for certificates representing the appropriate number of whole shares of post-Reverse Stock Split Common Stock.

Western Asset High Income Fund II Inc. Announces Preliminary Results of Transferable Rights Offering

Retrieved on: 
Tuesday, February 27, 2024

Western Asset High Income Fund II Inc. (NYSE: HIX) (CUSIP: 95766J-10-2) (“HIX” or the “Fund”) announced today the completion of its transferable rights offering (the “Offer”).

Key Points: 
  • Western Asset High Income Fund II Inc. (NYSE: HIX) (CUSIP: 95766J-10-2) (“HIX” or the “Fund”) announced today the completion of its transferable rights offering (the “Offer”).
  • Holders of Rights were entitled to purchase shares of common stock by submitting three Rights and the subscription price per share for each share purchased.
  • Shares of closed-end investment companies, such as the Fund, frequently trade at a discount from their net asset value.
  • The Fund is actively managed, but there is no guarantee that Western Asset’s investment decisions will produce the desired results.

Cenntro Electric Group Limited Announces Imminent Implementation of the Scheme of Arrangement

Retrieved on: 
Monday, February 26, 2024

Cenntro Electric Group Limited (NASDAQ: CENN) (“Cenntro” or “the Company”), a leading electric vehicle technology company with advanced, market-validated electric commercial vehicles, refers to the proposed scheme of arrangement in relation to which Cenntro will redomicile from Australia to the United States ("U.S.", the “Scheme”), and under which Cenntro will become a subsidiary of Cenntro Inc., a corporation incorporated in accordance with the laws of the state of Nevada ("HoldCo") for the purpose of effecting the Scheme.

Key Points: 
  • Cenntro Electric Group Limited (NASDAQ: CENN) (“Cenntro” or “the Company”), a leading electric vehicle technology company with advanced, market-validated electric commercial vehicles, refers to the proposed scheme of arrangement in relation to which Cenntro will redomicile from Australia to the United States ("U.S.", the “Scheme”), and under which Cenntro will become a subsidiary of Cenntro Inc., a corporation incorporated in accordance with the laws of the state of Nevada ("HoldCo") for the purpose of effecting the Scheme.
  • Cenntro is pleased to announce that the Scheme will be implemented tomorrow February 27, 2024, in accordance with the previously announced timeline (the “Implementation Date”).
  • On the Implementation Date, HoldCo will acquire all of the issued ordinary shares of Cenntro and exchange them for shares of common stock of HoldCo on a 1:1 basis.
  • The CUSIP number attributable to the Cenntro ordinary shares will change from Cenntro’s CUSIP number—Q6519V120, to HoldCo’s CUSIP number—150964104 on the Implementation Date.